TY - JOUR T1 - Bidirectional contact tracing dramatically improves COVID-19 control JF - medRxiv DO - 10.1101/2020.05.06.20093369 SP - 2020.05.06.20093369 AU - William J. Bradshaw AU - Ethan C. Alley AU - Jonathan H. Huggins AU - Alun L. Lloyd AU - Kevin M. Esvelt Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/14/2020.05.06.20093369.abstract N2 - Contact tracing is critical to controlling COVID-19, but most protocols only “forward-trace” to notify people who were recently exposed. Using a stochastic branching-process model, we show that “bidirectional” tracing to identify infector individuals and their other infectees robustly improves outbreak control, reducing the effective reproduction number (Reff) by at least ∼0.3 while dramatically increasing resilience to low case ascertainment and test sensitivity. Adding smartphone-based exposure notification can further reduce Reff by 0.25, but only if nearly all smartphones can detect exposure events. Our results suggest that with or without digital approaches, implementing bidirectional tracing will enable health agencies to control COVID-19 more effectively without requiring high-cost interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by gifts from the Reid Hoffman Foundation and the Open Philanthropy Project (to K.M.E.) and cluster time granted by the COVID-19 HPC-1 consortium (MCB20071 to K.M.E.). E.C.A. was supported by a fellowship from the Open Philanthropy Project. A.L.L. is supported by the Drexel Endowment (NC State University).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode for configuring and running the model is publicly available at https://github.com/willbradshaw/covid-bidirectional-tracing. https://github.com/willbradshaw/covid-bidirectional-tracing ER -